Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Pacific Edge Signs First Commercial Agreement in Singapore


Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has reached a commercial agreement with Raffles Diagnostica Pte Ltd to offer its suite of Cxbladder tests in Singapore.

Under the terms of the agreement, Raffles Diagnostica Pte Ltd, a wholly owned subsidiary of the Raffles Medical Group (RMG) will coordinate the specimen collection, shipping and reporting of Cxbladder tests for RMG urologists for the detection and management of bladder cancer for Raffles’ patients in Singapore.

This is the first commercial agreement to be signed by Pacific Edge in Singapore, where the company has established a base for its investigation into the opportunity for Cxbladder tests within South East Asia. User Programmes are currently being run in the majority of the large private hospitals in the country and the focus remains on transitioning these into commercial customers once these studies have concluded.

Raffles Medical Group is a leading integrated private healthcare provider in Asia, operating medical facilities in 13 cities throughout Singapore, China, Japan, Vietnam and Cambodia and caring for over 2 million patients and more than 6,800 corporate clients each year. RMG is the only private medical provider in Singapore to own and operate a fully integrated healthcare organisation, which includes Raffles Hospital in Singapore.

CEO of Pacific Edge, David Darling, commented: “We are delighted to work with the prestigious Raffles Medical Group in Singapore and whilst this is a relatively small commercial proposition for Pacific Edge, it offers a significant stepping stone into the Raffles Medical Group across South East Asia. The region remains an exciting proposition for Pacific Edge with approximately 9,500 urologists and an estimated 1.8 million potential tests.”


© Scoop Media

Business Headlines | Sci-Tech Headlines


Smelter: Tiwai Deal Gives Time For Managed Transition

Today’s deal between Meridian and Rio Tinto for the Tiwai smelter to remain open another four years provides time for a managed transition for Southland. “The deal provides welcome certainty to the Southland community by protecting jobs and incomes as the region plans for the future. The Government is committed to working on a managed transition with the local community,” Grant Robertson said. More>>


Economy: Strong Job Ad Performance In Quarter Four

SEEK Quarterly Employment Report data shows a positive q/q performance with a 19% national growth in jobs advertised during Q4 2020, which includes October, November and December. Comparing quarter 4, 2020, with the same quarter in 2019 shows that job ad volumes are 7% lower...More>>

NIWA: 2020 - NZ’s 7th-warmest Year On Record

The nationwide average temperature for 2020, calculated using stations in NIWA’s seven-station temperature series which began in 1909, was 13.24°C (0.63°C above the 1981–2010 annual average). New Zealand’s hottest year on record remains 2016, when... More>>

Quotable Value New Zealand: Property Market Set To Cool From Sizzling To Warm In 2021

Nostradamus himself could not have predicted the strange series of events that befell our world in 2020 – nor the wild trajectory of New Zealand’s property market, which has gone from “doom and gloom” to “boom and Zoom” in record time. Even ... More>>

PriceSpy: Research Reveals How Shopping Behaviours Have Changed This Christmas

According to a new survey* from PriceSpy , almost 50 per cent of Kiwis are looking to shop locally this Christmas in light of Covid-19; The research also found consumers are changing their shopping habits, with one in seven (14 per cent) getting super-organised ... More>>

Commerce Commission: Noel Leeming Group Warned For Making Delivery Representations Without Reasonable Grounds During COVID-19 Lockdown

Noel Leeming Group has been warned by the Commerce Commission for making delivery representations about two products which, in the Commission’s view, it did not have reasonable grounds for at the time the representations were made. The warning ... More>>